Francesca Santilli | Signal Transduction Mechanisms | Research Excellence Award

Published on by Cell Biologist

Prof. Francesca Santilli | Signal Transduction Mechanisms | Research Excellence Award

Department of Medicine and Aging Science, University of Chieti-Pescara “G. d’Annunzio”Chieti | Italy

Francesca Santilli, MD, PhD, is a leading physician-scientist whose work has substantially advanced the understanding of platelet biology, thrombo-inflammation, and cardio-metabolic disease. Her research focuses on mechanisms of platelet activation, interindividual variability in response to low-dose aspirin, and the interplay between inflammation, oxidative stress, and metabolic dysfunction. She has led major national and international projects, including studies on oxidative stress regulation in aspirin-treated diabetes, peripheral blood megakaryocyte maturation, and the effects of JAK inhibitors on thrombopoiesis in inflammatory disease. Her work has also contributed key insights into biomarkers—such as proteomic signatures, microRNAs, and extracellular vesicles—for cardiovascular and metabolic risk stratification. Additional research explores megakaryocyte biology, accelerated platelet turnover, and the impact of emerging therapies including GLP-1 receptor agonists, SGLT2 inhibitors, and PCSK9 inhibitors. Through extensive collaborations across molecular medicine, proteomics, rheumatology, cardiology, and infectious diseases, she has established interdisciplinary frameworks linking platelet function to diabetes, obesity, MASLD, and vascular disease. With over 160 high-impact publications and leadership roles in several scientific networks, her research continues to inform clinical translation and therapeutic optimization in thrombosis, hemostasis, and metabolic disorders.

Profiles: Google Scholar | Scopus

Featured Publications: 

antilli, F., Vazzana, N., Liani, R., Guagnano, M. T., & Davì, G. (2012). Platelet activation in obesity and metabolic syndrome. Obesity Reviews, 13(1), 27–42.

Santilli, F., Rocca, B., De Cristofaro, R., Lattanzio, S., Pietrangelo, L., Habib, A., & Patrono, C. (2009). Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: Implications for aspirin “resistance.” Journal of the American College of Cardiology, 53(8), 667–677.

Rocca, B., Santilli, F., Pitocco, D., Mucci, L., Petrucci, G., Vitacolonna, E., … & Patrono, C. (2012). The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. Journal of Thrombosis and Haemostasis, 10(7), 1220–1230.

Caricato, A., Conti, G., Della Corte, F., Mancino, A., Santilli, F., Sandroni, C., … & Antonelli, M. (2005). Effects of PEEP on the intracranial system of patients with head injury and subarachnoid hemorrhage: The role of respiratory system compliance. Journal of Trauma and Acute Care Surgery, 58(3), 571–576.

Santilli, F., Vazzana, N., Bucciarelli, L. G., & Davì, G. (2009). Soluble forms of RAGE in human diseases: Clinical and therapeutical implications. Current Medicinal Chemistry, 16(8), 940–952.

Di Castelnuovo, A., Bonaccio, M., Costanzo, S., Gialluisi, A., Antinori, A., … Santilli, F., … & Iacoviello, L. (2020). Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: Survival analysis and machine learning-based findings from the multicentre Italian study. Nutrition, Metabolism and Cardiovascular Diseases, 30(11), 1899–1913.

Vazzana, N., Santilli, F., Cuccurullo, C., & Davì, G. (2009). Soluble RAGE in internal medicine. Internal and Emergency Medicine, 4(5), 389–401.

Davì, G., Santilli, F., & Patrono, C. (2010). Nutraceuticals in diabetes and metabolic syndrome. Cardiovascular Therapeutics, 28(4), 216–226.

Chiarelli, F., Santilli, F., & Mohn, A. (2000). Role of growth factors in the development of diabetic complications. Hormone Research in Paediatrics, 53(2), 53–67.

Davì, G., Chiarelli, F., Santilli, F., Pomilio, M., Vigneri, S., Falco, A., … & Basili, S. (2003). Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: Role of interleukin-6 and disease duration. Circulation, 107(25), 3199–3203.

Manigrasso, M. R., Ferroni, P., Santilli, F., Taraborelli, T., Guagnano, M. T., … & Davì, G. (2005). Association between circulating adiponectin and interleukin-10 levels in android obesity: Effects of weight loss. The Journal of Clinical Endocrinology & Metabolism, 90(10), 5876–5879.

Ahmed Sobhy Abdelrahim Abdallah Darwish | Cell Biology | Research Excellence Award

Published on by Cell Biologist

Dr. Ahmed Sobhy Abdelrahim Abdallah Darwish | Cell Biology | Research Excellence Award

Zagazig University & Egyptian International Pharmaceutical Industries Company, EIPICO | Egypt

Ahmed Sobhy Abdelrahim Abdallah Darwish is a highly accomplished analytical chemist with extensive expertise in analytical methodologies and chemical research. His academic journey demonstrates a consistent commitment to scientific rigor, progressing from a strong foundation in chemistry and physics to advanced studies in analytical chemistry. He has completed a diploma in analytical chemistry with distinction, a pre-master qualification with outstanding performance, and a master’s degree in analytical chemistry. Currently pursuing a Ph.D. in the same field, his research is centered on the development, optimization, and validation of analytical techniques for pharmaceutical and industrial applications. His work emphasizes precision, reliability, and innovation in chemical analysis, including method development for complex matrices, quality control protocols, and instrumental analysis techniques. His contributions aim to enhance the accuracy and efficiency of laboratory workflows, ensuring robust and reproducible results in pharmaceutical and chemical research. Additionally, he demonstrates proficiency in data interpretation, statistical analysis, and experimental design, contributing to high-quality scientific outcomes. His ongoing research reflects a commitment to advancing analytical chemistry through both theoretical insights and practical applications, positioning him as a significant contributor to the field and a strong candidate for recognition in research excellence.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications: 

Ma, J. K., Darwish, A. S., Al Ali, A., Abdelazim, A. M., Darwish, W. S., Li, X., & Huang, X. C. (2025). An ecologically sound HPLC determination of LEVOMENOL in topical therapies using a certified reference material with green properties. Results in Chemistry, 13, 102338.

Alenezi, S. S., Gouda, A. A., El Sheikh, R., Badahdah, N. A., Alzuhiri, M. E., & others. (2025). Environmental sustainability profiles assessment of HPLC stability indicating method for quantitation of piracetam and vincamine in pharmaceutical medications. Talanta Open, 11, 100407.

Darwish, A. S., Zaki, M. S. A., Salih, A. G. K. A., Ellatif, M. A., Patel, A. A., Mallick, A. K., & others. (2025). A simple eco‐friendly stability‐indicating HPLC method for determination of NETILMICIN in bulk and ophthalmic solution. Biomedical Chromatography, 39(8), e70152.

Gouda, A. A., Elsheikh, R., Eldien, A. S., & Darwish, A. S. (2025). Development and validation of stability indicating RP-HPLC method for simultaneous determination of simvastatin and fenofibrate in bulk and dosage form. Bulletin of Faculty of Science, Zagazig University, 2025(3), 134–146.

Huang, X. C., Darwish, A. S., Darwish, W. S., Chen, R. M., & Ma, J. K. (2025). Green rapid HPLC method for testing retinol and tocopherol in ophthalmic gels. Talanta Open, 100538.

Darwish, A. S., Gouda, A. A., & Eldien, A. S. (2025). Simple validated approach to quantify valsartan and sacubitril in medications using liquid chromatography. Bulletin of Faculty of Science, Zagazig University, 2025(3), 216–229.

Darwish, W. S. D., Zaki, M. S. A., Salih, A. G. K. A., & others. (2025). Developing a sensitive, ecological, and economic HPLC method for the concurrent quantification of KOLCHICINE and KHELLIN, used in bulk and sachet pharmaceuticals. Microchemical Journal, 114716.

Ma, J. K., Chen, X. Y., Zhang, N., Darwish, A. S., Gouda, A. A., El Sheikh, R., & others. (2025). A straightforward HPLC approach to testing butylated hydroxytoluene, an antioxidant, in pure and topical anti-burn gels; evaluation of greenness, blueness, and whiteness grades. Talanta Open, 100565.

Huang, X. C., Darwish, A. S., Darwish, W. S., Zaki, M. S. A., Lin, Y. T., Liang, N. L., & Ma, J. K. (2025). Ecologically conscious profiles assessments for economic, and concurrent HPLC detection of chlordiazepoxide and clidinium bromide in bulk and tablets solid dosage form. Results in Chemistry, 1, 102739.

Meenakshi | Signal Transduction Networks | Research Excellence Award

Published on by Cell Biologist

Assoc. Prof. Dr. Meenakshi | Signal Transduction Networks | Research Excellence Award

Chandigarh University | India

Dr. Meenakshi Munjal is an active researcher in the field of wireless communication, contributing extensively to advancements in emerging communication technologies. Over the past several years, she has maintained a strong research trajectory, completing one funded research project and producing a substantial body of scholarly work. Her research output includes more than 30 Scopus-indexed publications and a total citation count of 100, reflecting the growing impact of her contributions within the scientific community. She has authored one book with an ISBN and has two patents published or under process, demonstrating her commitment to innovation and applied research in communication systems. In addition to her publications, she has published eight peer-reviewed journal articles across SCI and Scopus-indexed platforms, strengthening the scientific understanding of wireless networks, signal processing, and communication technologies. Her work aligns with contemporary challenges in wireless systems, contributing to enhanced network performance, reliability, and efficiency. She also holds three professional memberships, supporting collaborative engagement within the research ecosystem. Overall, her research contributions highlight a sustained focus on innovation, scholarly excellence, and the advancement of wireless communication technologies

Profiles: Google Scholar | Scopus | Orcid

Featured Publications: 

Munjal, M., & Singh, N. P. (2018). Utility aware network selection in small cell. Wireless Networks, 1–14.

Munjal, M., & Singh, N. P. (2019). Group mobility by cooperative communication for high speed railway. Wireless Networks, 25(7), 3857–3866.

Gupta, S. (2014). A review and comprehensive comparison of image denoising techniques. Proceedings of the International Conference on Computing for Sustainable Global Development, 1–6.

Munjal, M., & Singh, N. P. (2019). QoS and cost-aware protocol selection for next generation wireless network. Journal of Network and Systems Management, 27(2), 327–350.

Munjal, M., & Singh, N. P. (2017). Improved network selection for multimedia applications. Transactions on Emerging Telecommunications Technologies, 28(5), e3121.

Munjal, M., & Singh, N. P. (2016). A comparative study of cooperative and non-cooperative game theory in network selection. Computational Techniques in Information and Communication Technologies Conference Proceedings, 1–5.

Meenakshi, G., & Gupta, S. (2014). Advanced level cyclic gray codes with application. International Journal of Electronics Communication and Computer Technology, 1–6.

Munjal, M., & Singh, N. P. (2020). Low cost communication for high speed railway. Wireless Personal Communications, 111(1), 163–178.

Munjal, M. (2024). A comprehensive review of wireless body area network in medical applications. AIP Conference Proceedings, 3100(1), 040013.

Munjal, M., & Dev, S. (2021). Utility based handoff decision for Internet of Everything (IoE). Photonics & Electromagnetics Research Symposium (PIERS) Proceedings, 1396–1405.

Singh, I., & Munjal, M. (2025). Intelligent network selection mechanisms in the Internet of Everything system. IEEE Access.

Munjal, M., Kaistha, K., Gupta, P., Sardana, L., Verma, R., & Verma, S. (2024). Handoff management using RSS in a heterogeneous system. AIP Conference Proceedings, 3072(1), 030003.

Long Yu | Biosensor | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Long Yu | Biosensor | Best Researcher Award

Assoc. Prof. Dr. Long Yu | Wuhan University | China

Dr. Long Yu is a highly accomplished Han Chinese researcher, currently serving as a Postdoctoral Fellow in Clinical Medicine at Wuhan University. With a deep passion for pharmaceutical analysis, he has pioneered innovative approaches using lanthanide-based metal-organic frameworks (Ln-MOFs). His academic journey has been marked by excellence, including direct admission to a Ph.D. program and multiple national-level scholarships. Dr. Yu has published over 20 high-impact SCI papers, many in top-tier journals such as Advanced Materials, ACS Nano, and Analytical Chemistry. Recognized for his independent research capabilities, he has secured major national funding, including the NSFC Youth Project and China Postdoctoral Science Foundation grant. His work is shaping the future of biosensing and molecular diagnostics, especially in nucleic acid detection. Dr. Yu’s remarkable academic achievements, innovative research direction, and collaborative impact make him an outstanding candidate for the Best Researcher Award.

Publication Profile: 

Orcid

Education:

Dr. Long Yu’s educational background reflects a consistent trajectory of academic excellence. He completed his Bachelor of Science in Pharmacy at Shihezi University, where he graduated and was directly admitted to a Ph.D. program without an entrance exam. He pursued a Direct-Ph.D. in Pharmacy at Wuhan University, under the mentorship of Prof. Yuxiu Xiao. His doctoral research focused on the rational design and application of programmable lanthanide-based metal-organic frameworks (Ln-MOFs) in pharmaceutical analysis. Currently, he is a Postdoctoral Fellow in Clinical Medicine at Wuhan University, guided by Professors Gaosong Wu and Xiang Zhou. Through his academic journey, Dr. Yu has demonstrated strong interdisciplinary capabilities, combining pharmaceutical sciences, materials chemistry, and biosensing technology to advance the field of molecular diagnostics.

Experience:

Dr. Long Yu has cultivated deep expertise in biosensors and pharmaceutical analysis throughout his academic and research journey. He is currently a Postdoctoral Fellow in Clinical Medicine at Wuhan University, working on translational biosensing technologies with Professors Gaosong Wu and Xiang Zhou. He earned his Ph.D. in Pharmacy at Wuhan University under the supervision of Prof. Yuxiu Xiao, where he led several high-impact research projects on programmable metal-organic frameworks (MOFs). His undergraduate foundation was built at Shihezi University , where he graduated among the top of his class. Dr. Yu has served as the principal investigator for five competitive research grants, including prestigious national funding. His academic footprint includes 21 SCI-indexed publications and significant contributions to both theoretical research and practical biosensor development. He excels at multidisciplinary collaboration, combining chemistry, materials science, and clinical application—demonstrating both leadership and innovation in his research.

Awards and Honors:

Dr. Long Yu has received multiple accolades that highlight his academic and research excellence. During his Ph.D., he was awarded the National Scholarship for Graduate Students twice, a prestigious recognition of outstanding academic performance and research capabilities in China. He also received the 1st Prize for Oral Presentation at the National Academic Symposium for Pharmacy Postgraduates in , and the Excellent Poster Award at the 9th National Conference on Drug Analysis in the same year. In addition to academic awards, he has secured several competitive grants as the Principal Investigator, including the National Natural Science Foundation of China Youth Project, the China Postdoctoral Science Foundation General Program, and the Hubei Province Postdoctoral Innovation Talent Program. These achievements demonstrate both national-level recognition and institutional confidence in his independent research potential, marking him as one of the leading young scientists in his field.

Research Focus:

Dr. Long Yu’s research is centered on the rational design of programmable lanthanide-based metal-organic frameworks (Ln-MOFs) for pharmaceutical analysis and biosensing applications. His work bridges materials science and biomedical engineering, enabling high-performance detection platforms for nucleic acids, neurotransmitters, kinases, and epigenetic modifications. He has developed Ln-MOF-integrated systems with excellent selectivity, sensitivity, and biocompatibility for real-time monitoring and clinical diagnostics. A notable feature of his research is the integration of MOF materials with cutting-edge technologies such as CRISPR-Cas, nanozymes, and multivariate sensing platforms. His innovative designs contribute to amplification-free gene mutation detection, ultra-efficient nucleic acid extraction, and responsive ctDNA biosensors. Dr. Yu’s interdisciplinary approach not only expands the utility of MOFs in biomedicine but also paves the way for smart and customizable sensing systems. With 21 high-quality SCI publications and ongoing funded projects, his work is both academically significant and practically relevant in clinical diagnostics and precision medicine.

Publications Top Notes: 

  1.  Lanthanide MOF-Integrated CRISPR-Cas Technology for Amplification-Free Gene Mutation Assay

  2.  Customized Pyrophosphate Nanosensor Based on Lanthanide MOFs for Nucleic Acids Detection

  3.  Polarity Sensor Using Multivariate Lanthanide MOF for Biosensing Platforms

  4.  Levodopa Cascade Polymerization with MOF Nanozyme for Butyrylcholinesterase Dual-Mode Assay

  5.  Enhancing Kinase Detection via Programmable Lanthanide MOF with ATP-to-ADP Conversion

  6. Ultra-Efficient Nucleic Acids Extraction Using Programmable Lanthanide MOF

  7. Bioreaction-Compatible Bivariate Lanthanide MOF Sensor for ctDNA Detection

  8. Adaptable Cobalt MOF for DNA Epigenetic Modification Detection

  9. Trinity Strategy Using Perovskite Nanozyme for Biomarker Reporting

  10.  Nanoporous Crystalline Materials for Nucleic Acids Recognition

Conclusion:

In conclusion, Dr. Long Yu is highly suitable for the Best Researcher Award based on his exceptional research productivity, innovation in the design and application of Ln-MOFs, and substantial contributions to high-impact journals. His early career achievements, particularly as a postdoctoral fellow, show a promising trajectory that is well-aligned with the criteria of research excellence, originality, and potential societal impact. With continued international exposure, broader interdisciplinary collaboration, and efforts to translate research into clinical or industrial outcomes, Dr. Yu is not only deserving of the current award but is also poised to become a leading figure in his field in the years to come.

Yuxin Peng | Cell Adhesion Mechanisms | Best Researcher Award

Published on by Cell Biologist

Prof. Yuxin Peng | Cell Adhesion Mechanisms | Best Researcher Award

Prof. Yuxin Peng | Zhejiang University | China

Dr. Yuxin Peng is a distinguished researcher and educator in the field of biomedical and exercise science engineering. Currently serving as a ZJU 100 Young Professor at Zhejiang University, China, he has made significant strides in developing flexible sensors, smart wearable systems, and human–machine interaction technologies. With a Ph.D. and postdoctoral training at the National University of Singapore, his research integrates cutting-edge materials science, biomechanics, and AI-driven health monitoring systems. His work has been consistently published in high-impact journals like Science Advances, Advanced Science, IEEE Transactions, and Soft Robotics, reflecting both depth and innovation. Dr. Peng’s contributions are not only academic but also practical, with several of his innovations applied in rehabilitation, sports science, and robotics. His dedication and cross-disciplinary expertise make him a strong candidate for recognition such as the Best Researcher Award.

Publication Profiles: 

Orcid
Scopus

Education:

Dr. Yuxin Peng received his doctoral degree (Ph.D.) in an engineering-related discipline, laying a strong foundation in biomedical engineering, biomechanics, and sensor technologies. His early academic pursuits were rooted in multidisciplinary innovation, merging engineering principles with human physiology and robotics. To further deepen his scientific understanding, he pursued postdoctoral research at the prestigious National University of Singapore, focusing on biomedical systems and smart rehabilitation. During his academic training, Dr. Peng built expertise in wearable sensors, motion tracking systems, and soft robotics—technologies that play a crucial role in personalized healthcare and intelligent rehabilitation. His education trajectory demonstrates both depth and diversity, preparing him to address complex biomedical challenges with integrated, high-tech solutions. It also laid the groundwork for his future leadership roles and impactful research career at Zhejiang University, where he now mentors young researchers and leads innovation in health engineering.

Experience:

Dr. Yuxin Peng has built an impressive academic and research career spanning over a decade. He has been a ZJU 100 Young Professor at Zhejiang University, affiliated with the Institute of Exercise Science and Health Engineering. In this role, he leads interdisciplinary research projects in wearable technology, flexible sensors, and human motion analysis. Prior to this, he served as a Research Fellow at the Department of Biomedical Engineering, National University of Singapore, where he focused on intelligent health systems and rehabilitation technologies. His hands-on experience in global, high-tech research environments has allowed him to develop collaborations with experts in robotics, materials science, and medical engineering. He has supervised numerous projects and students, while continuously publishing in high-impact journals. His experience demonstrates a rare blend of academic rigor and real-world application, making him a leader in human-centered biomedical innovation and smart rehabilitation systems.

Research Focus:

Dr. Yuxin Peng’s research focuses on wearable systems, smart sensors, soft robotics, and biomedical signal processing for human motion monitoring and rehabilitation. His work addresses real-world problems such as gait analysis, joint motion detection, force sensing, and rehabilitation assistance. By integrating AI, flexible electronics, and biocompatible materials, he develops high-performance sensors and intelligent exosuits for applications in sports science, elderly care, and physical therapy. Notable innovations include graphene-based aerogels, hydrogel biosensors, and multi-feature neural networks for gesture recognition. His lab has also contributed to optical waveguide sensors, virtual reality rehabilitation, and MI-controlled exoskeletons. The overarching goal of his work is to enable non-invasive, real-time, and personalized health monitoring through smart technology. By pushing the boundaries of soft, adaptive, and human-interactive systems, Dr. Peng’s research is at the forefront of the next generation of intelligent biomedical engineering solutions.

Publications Top Notes:

  1. Hydroplastic Foaming of Graphene Aerogels and AI Tactile Sensors – Science Advances

  2. Underwater Instant Adhesive Hydrogel Interfaces for Robust Biosensing – Advanced Science

  3. Flexible Segmented Assemblable Fiber Optic Sensor for Multi-Joint Monitoring – Soft Robotics (Accepted)

  4. Calibration-Free Optical Waveguide Bending Sensor for Soft Robots – Soft Science

  5. Distributed Plantar 3D Force Measurement System – Sensors and Actuators A

  6. Superelastic Graphene Nanofibrous Aerogels for Intelligent Sign Language – Small

  7. Omnidirectional Soft Bending Sensor for Joint Monitoring – IEEE TIE

  8. Shank-RIO: Ranging-Inertial Odometry for Gait and Positioning – IEEE TIM

  9. Exosuit with Bidirectional Hand Support via Gesture Recognition – IEEE TNSRE

  10.  Advances in Flexible Bending Sensors and Applications – IJ Smart & Nano Materials

Conclusion:

In conclusion, Dr. Yuxin Peng exhibits all the qualities of a top-tier, award-worthy researcher. His work is characterized by scientific rigor, high-impact publication, and a vision for solving real-world healthcare challenges using cutting-edge sensor and robotics technologies. As a respected academic at Zhejiang University with a solid international research background, Dr. Peng has already contributed significantly to wearable health tech and rehabilitation sciences. His ability to combine soft material innovation, artificial intelligence, and biomechanics into novel human-machine interaction systems places him at the forefront of biomedical engineering research. While there is room for growth in the areas of commercialization and global academic engagement, his career trajectory, research excellence, and societal relevance of his innovations make him a highly deserving candidate for the Best Researcher Award.

Shima Shafiee | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Dr. Shima Shafiee | Cell Structure Analysis | Best Researcher Award

Dr. Shima Shafiee, Razi University, Iran

Shima Shafiee is an accomplished Iranian researcher specializing in computer systems architecture and bioinformatics, with a strong focus on machine learning applications in biological data analysis. She recently earned her Ph.D. in Computer Engineering from Razi University, where she focused on predictive modeling of protein-peptide binding interactions. Currently under consideration at the IDEL Lab, Shahid Bahonar University of Kerman, Shima has authored numerous national and international publications. With a rich background in algorithm optimization and artificial intelligence, her research stands at the intersection of computational biology, deep learning, and evolutionary algorithms. Shafiee’s work has contributed to the development of predictive tools in bioinformatics, such as DP-site and SPPPred, and she consistently ranks at the top of her academic cohort. Her ability to integrate traditional computer engineering concepts with advanced biological research makes her a notable candidate for the Best Researcher Award.

Publication Profile: 

Google Scholar

Strengths for the Award:

  1. Strong Academic Foundation
    Dr. Shafiee has a stellar academic record, graduating first in her Ph.D. class at Razi University with a CGPA of 3.77 and a thesis grade of 3.98, under the supervision of respected experts in computer engineering and bioinformatics.

  2. Innovative Interdisciplinary Research
    Her research bridges computer systems architecture, machine learning, and bioinformatics, with notable contributions to protein-peptide binding prediction, a critical domain in drug discovery and computational biology.

  3. High-Impact Publications
    She has published in IEEE/ACM Transactions, Applied Soft Computing, and Methods, reflecting both quality and visibility in international forums. Tools like SPPPred and DP-site demonstrate her practical impact in bioinformatics.

  4. Research Originality and Versatility
    Dr. Shafiee has developed hybrid models combining genetic programming, support vector machines, and deep learning, with practical tools and open-source contributions.

  5. Early Recognition and Outreach
    She has been active in academic dissemination since 2015, with selected papers in national and international conferences, showing early promise and consistency.

  6. Teaching and Mentorship
    Through her roles as a lecturer at multiple institutions, she has contributed to academic growth at the grassroots level.

Areas for Improvement:

  1. International Collaboration & Visibility
    While her publication quality is strong, Dr. Shafiee could expand her global visibility through collaborations with international research labs, EU Horizon, or NIH-funded projects.

  2. Post-Ph.D. Grant Applications
    She could benefit from applying for independent research grants or postdoctoral fellowships to lead projects that could shape the future of AI in biology.

  3. Open-Source Software and Data Availability
    While her models are impactful, increased accessibility via open-source repositories (e.g., GitHub) would boost reproducibility and encourage broader adoption.

  4. Industry Impact Metrics
    More emphasis on industry collaborations, patents, or application of models in clinical/biotech settings would enhance translational impact.

Education:

Shima Shafiee completed her Ph.D. in Computer Engineering (2016–2024) from Razi University, specializing in Computer Systems Architecture. Her dissertation titled “Application of learning-based models in predicting of protein-peptide binding interactions” earned her a thesis grade of 3.98/4.00 and an overall CGPA of 3.77. She worked under the guidance of Dr. Abdolhossein Fathi and Dr. Ghazaleh Taherzadeh, focusing on bioinformatics using deep learning, ensemble learning, and evolutionary algorithms. Prior to her Ph.D., she was ranked third in her Master’s program (2015). Shafiee’s educational background is rooted in computational problem-solving, algorithm development, and cross-disciplinary research involving biological data. Her consistent academic excellence and high-ranking performance culminated in her being recognized as the top Ph.D. student in 2025, a testament to her dedication and scholarly capabilities. Her education blends rigorous theory with innovative applied research, making her exceptionally well-prepared for high-impact contributions in academia and industry.

Experience:

Shima Shafiee’s experience spans both academic and applied computer engineering roles. She began her journey with an internship at Kimia Pardaz Pars Company (2013). Between 2015 and 2016, she served as a lecturer for computer fundamentals at Fajr High School and Al-Zahra Seminary School in Jiroft, where she taught introductory computer science to pre-university students. These experiences highlight her foundational teaching skills and outreach to educational institutions in her community. Her major academic contribution began during her Ph.D., where she collaborated with IDEL Lab and contributed to developing tools like SPPPred and DP-site, combining genetic programming, support vector machines, and deep learning to predict protein-peptide binding regions. Her experience uniquely blends educational outreach, algorithmic development, and publication-driven research in machine learning, optimization, and computational biology, reflecting her versatility and impact across the scientific and academic spectrum.

Awards & Honors:

Shima Shafiee has earned multiple distinctions recognizing her academic and research excellence. In 2015, she was named the third-place student in her Master’s program, demonstrating early academic excellence. Her continuous dedication to research and scholarship led her to be recognized as the first-place student in her Ph.D. program in 2025. One of her papers was selected at the 2nd International Congress of Electrical Engineering, Computer Science, and Information Technology (2015), highlighting the innovation and relevance of her early research in optimization algorithms. Her high publication output, including appearances in top-tier venues like IEEE/ACM Transactions on Computational Biology and Bioinformatics and Applied Soft Computing, reflects a consistent standard of excellence. These honors collectively showcase her as a standout figure in her field, with both academic and applied contributions acknowledged at national and international levels.

Research Focus:

Shima Shafiee’s research lies at the intersection of machine learning, bioinformatics, and computational systems engineering. Her primary focus is the prediction of protein-peptide binding interactions using intelligent algorithms such as genetic programming, ensemble models, and deep learning techniques. She has proposed several innovative hybrid models combining sequence-based and structure-based features to identify critical interaction residues. Her doctoral thesis and publications have led to the development of tools like SPPPred and DP-site, which aid in biological sequence analysis, with applications in drug discovery, protein function prediction, and biomedical engineering. Shafiee also has a strong background in optimization algorithms, especially particle swarm optimization (PSO), applied to computationally intensive problems like bin packing. Her ability to blend theoretical computing with practical biological data analysis makes her contributions valuable to both computational scientists and biologists, and positions her as a leading candidate for research recognition awards in AI and bioinformatics.

Publications Top Notes: 

  • 🧠 SPPPred: sequence-based protein-peptide binding residue prediction using genetic programming and ensemble learning (IEEE/ACM TCBBS, 2022)

  • 🔍 Prediction of protein–peptide-binding amino acid residues regions using machine learning algorithms (CSICC, 2021)

  • 🧬 Combination of genetic programming and SVM-based prediction of protein-peptide binding sites (Journal of Computing and Security, 2021)

  • 🧪 Prediction of protein–peptide binding residues using classification algorithms (IEEE Bioengineering Conf, 2020)

  • 🧠 A Review of the Uses of AI in Protein Research (Peptide Science Conf, 2019)

  • 🤖 DP-site: dual deep learning method for protein-peptide interaction site prediction (Methods, 2024)

  • 🧬 Protein-peptide interaction region prediction using generative sampling & ensemble DL (Applied Soft Computing, 2025)

  • 🧠 Comparing classification vs. segmentation predictors in protein-peptide interaction (CSICC, 2025)

  • 🧬 Leveraging structure-based and learning-based predictors in protein-peptide interaction (ICCKE, 2024)

  • 📘 Application of learning-based models in protein-peptide binding (Ph.D. Dissertation, 2024)

Conclusion:

Dr. Shima Shafiee is a highly suitable candidate for the Best Researcher Award based on her academic excellence, interdisciplinary research achievements, and consistent contributions to the fields of artificial intelligence and bioinformatics. Her ability to bridge computer science and biological challenges has resulted in meaningful and applicable solutions. She has displayed originality, depth, and foresight in her work, developing novel methods that align with modern computational biology trends.

Emmanuelle Van Erck-Westergren | Equine microbiota | Outstanding Contribution Award

Published on by Cell Biologist

Prof. Dr. Emmanuelle Van Erck-Westergren | Equine microbiota | Outstanding Contribution Award

Prof. Dr. Emmanuelle Van Erck-Westergren, Equine Sports Medicine Practice, Belgium

Dr. Emmanuelle van Erck-Westergren is a renowned veterinarian specializing in equine internal medicine and sports medicine. She is a diplomate of both the European College of Equine Internal Medicine (ECEIM) and the European College of Veterinary Sports Medicine and Rehabilitation (ECVSMR). Dr. van Erck-Westergren earned her DVM and PhD at the University of Liège, focusing on equine respiratory diseases. She founded the Equine Sports Medicine Practice (ESMP) in Belgium, where she leads a team dedicated to elite equine performance diagnostics. A trusted expert for the Fédération Équestre Internationale (FEI), she also serves as president of the Belgian Equine Practitioners Society (BEPS). Her prolific academic output includes scientific publications, lectures at international conferences, and editorial contributions, notably co-editing the third edition of Equine Sports Medicine and Surgery. Her work bridges clinical expertise with high-impact research, benefitting elite equine athletes worldwide.

Publication Profile: 

Orcid

Scopus

✅ Strengths for the Award:

  1. Dual Specialization & Diplomate Status

    • Certified by both the European College of Equine Internal Medicine (ECEIM) and European College of Veterinary Sports Medicine and Rehabilitation (ECVSMR)—a rare and highly prestigious achievement demonstrating clinical and research excellence.

  2. Academic Contributions

    • Over 10 high-impact publications and book chapters (2024–2025 alone), including contributions to the gold-standard veterinary textbook Equine Sports Medicine and Surgery (3rd Edition), in which she is co-editor.

  3. Foundational Research

    • PhD in equine respiratory diseases—her foundational work has real-world implications for the health and athletic longevity of sport horses.

  4. Global Impact and Leadership

    • Founder of the Equine Sports Medicine Practice (ESMP), servicing elite sport horses globally.

    • President of the Belgian Equine Practitioners Society (BEPS) and expert for the FEI, influencing international veterinary policy.

  5. Interdisciplinary & Translational Work

    • Her research spans virology, exercise physiology, gastroenterology, and equine biomechanics, showcasing her ability to integrate science with applied veterinary sports medicine.

⚖️ Areas for Improvement:

  1. Wider Interdisciplinary Collaboration

    • While her work is strong in traditional veterinary fields, collaboration with emerging tech (e.g., AI/biomechanical sensors) could expand the scope and impact of her research.

  2. Public Outreach and Knowledge Translation

    • Increased visibility through public science communication, open-access publications, or educational content for non-academic stakeholders (e.g., horse owners, trainers) would enhance the societal reach of her findings.

  3. Mentorship Record (Unstated)

    • No information was provided on her mentorship or training of the next generation of veterinary researchers—although this may exist, it should be highlighted if available.

🎓 Education:

Dr. van Erck-Westergren graduated as a Doctor of Veterinary Medicine (DVM) from the University of Liège in Belgium. Pursuing her passion for equine health, she completed a PhD at the same university, with a research focus on equine respiratory diseases—an area central to athletic performance in horses. Her postgraduate training led to board certification from two prestigious veterinary colleges: the European College of Equine Internal Medicine (ECEIM) and the European College of Veterinary Sports Medicine and Rehabilitation (ECVSMR). These dual diplomate titles mark her as one of a select group of veterinarians with exceptional expertise in both internal medicine and athletic performance of horses. Her education is not only grounded in clinical excellence but also in scientific rigor, making her a key academic and practical contributor in the veterinary field.

👩‍⚕️ Experience:

Dr. van Erck-Westergren has over two decades of experience in equine veterinary medicine, specializing in the health and performance of sport horses. She founded the Equine Sports Medicine Practice (ESMP) in Belgium, where she provides advanced diagnostic and rehabilitation services for elite equine athletes. Her clientele includes top-level international competitors across disciplines such as dressage, eventing, and racing. She has served as an expert advisor to the Fédération Équestre Internationale (FEI), lending her insight to regulatory and clinical frameworks for equestrian sports. As the president of the Belgian Equine Practitioners Society (BEPS), she actively shapes veterinary policy and continuing education. In academia, she contributes extensively through authorship of peer-reviewed papers, textbook chapters, and international lectures, reinforcing her reputation as both a clinician and a thought leader.

🔬 Research Focus:

Dr. van Erck-Westergren’s research centers on equine sports medicine, with a strong focus on respiratory function, cardiovascular fitness, exercise physiology, and performance diagnostics. Her PhD on equine respiratory disease laid the foundation for a prolific research career that integrates field-based diagnostics with clinical intervention. She is particularly interested in how subclinical conditions—such as mild respiratory infections or gastric issues—impact performance in elite horses. Recent studies include predictive modeling of racehorse performance, the physiological impacts of diet on gastric health and behavior, and the use of advanced endoscopy in diagnostics. Her approach bridges science and sport, often conducting studies directly on high-performance horses during training or competition. She also contributes to veterinary education as a chapter author and editor of the seminal textbook Equine Sports Medicine and Surgery, ensuring her research continues to influence the field globally.

📚 Publications Top Notes: 

  • 🦠 Respiratory viruses affecting health and performance in equine athletes (Virology, 2025)

  • 🐎 Cardiovascular Fitness and Stride Acceleration in Race-Pace Workouts for the Prediction of Performance in Thoroughbreds (Animals, 2024)

  • 🔍 Endoscopic examination of the respiratory tract (Equine Respiratory Endoscopy, 2024)

  • 🧾 Endoscopy in pre-purchase examinations (Equine Respiratory Endoscopy, 2024)

  • 📘 Equine Sports Medicine and Surgery: Basic and Clinical Sciences of the Equine Athlete, Third Edition (2024)

  • 🏃‍♂️ Exercise Testing in the Field (Chapter in Equine Sports Medicine and Surgery, 2024)

  • 🍽️ Improvement of gastric disease and ridden horse pain ethogram scores with diet adaptation in sport horses (Journal of Veterinary Internal Medicine, 2024)

  • 📝 Preface (Equine Sports Medicine and Surgery, 2024)

  • 🌐 The Connected Horse (Chapter in Equine Sports Medicine and Surgery, 2024)

  • 🏇 Veterinary Aspects of Conditioning, Training, and Competing Dressage Horses (Chapter in Equine Sports Medicine and Surgery, 2024)

🧾 Conclusion:

Dr. Emmanuelle van Erck-Westergren exemplifies the criteria of the Research for Outstanding Contribution Award through her blend of scholarly excellence, clinical leadership, and translational impact on equine health and performance. Her dual-board certification, editorship of a seminal textbook, and active participation in shaping global veterinary policies place her in the top tier of veterinary researchers.

Eunmiri Roh | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Prof. Eunmiri Roh | Molecular Mechanisms Signaling | Best Researcher Award

Prof. Eunmiri Roh, Department of Cosmetic Science, Kwangju Women’s University, South Korea

Dr. Eunmiri Roh is an accomplished biomedical scientist and Assistant Professor in the Department of Cosmetic Science at Kwangju Women’s University, Republic of Korea. With a strong foundation in microbiology and pharmaceutical sciences, Dr. Roh has established herself in the field of skin cancer biology and cosmetic science. Her research explores cellular and molecular pathways in skin carcinogenesis, melanogenesis, photoaging, and chemoprevention, emphasizing UV-induced damage and pigmentation disorders. She has published extensively in top-tier international journals and has collaborated with leading institutions, including the University of Minnesota. Dr. Roh’s dedication to integrating science with practical beauty and health solutions positions her as a leading figure in her field. Her exceptional contributions have earned her multiple research honors, and she continues to innovate at the intersection of pharmaceutical science and cosmetology.

Publication Profile:

Google Scholar

Orcid

✅ Strengths for the Award:

  1. High-Impact Research Portfolio
    Dr. Roh has produced a consistent stream of peer-reviewed publications in high-impact international journals, such as Biochemical Pharmacology, Cancer Research, Journal of Investigative Dermatology, and Cells, reflecting her solid global research presence.

  2. Focused and Societally Relevant Research
    Her primary focus—UV-induced skin carcinogenesis, pigmentation disorders, and chemoprevention—addresses pressing issues in dermatology and cosmetic health, aligning with public health interests and the cosmetic industry’s innovation goals.

  3. Interdisciplinary Expertise
    Dr. Roh’s training in biochemistry, pharmacy, and microbiology supports a multidisciplinary research approach, which is evident in her collaboration with dermatologists, chemists, and pharmacologists.

  4. Award-Winning Excellence
    She has earned multiple national and international research awards, including from the Korean Society of Microbiology and Biotechnology, the Korean Society of Cancer Prevention, and The Hormel Institute (USA), validating her scientific merit.

  5. Strong International Collaboration
    Collaboration with globally recognized institutions like the University of Minnesota and The Hormel Institute reflects the international relevance and applicability of her research.

  6. Translational Research Impact
    Dr. Roh’s research bridges basic science and application—discovering bioactives for cosmetics and drug delivery systems, highlighting practical impact in dermatology and consumer health.

⚙️ Areas for Improvement:

  1. Leadership in Independent Grants
    While publication output is impressive, securing independent competitive research funding (e.g., national research grants, PI-led international projects) would further reinforce her research leadership.

  2. Mentorship and Academic Development
    Enhanced documentation of her mentorship role—particularly training graduate students, Ph.D. candidates, or postdoctoral researchers—would highlight her academic influence beyond publications.

  3. Commercial Translation or Patents
    Filing patents or commercializing products/formulations related to her discoveries (e.g., natural anti-pigmentation agents or UV protectants) could amplify her impact and innovation metrics.

  4. Greater Engagement in Scientific Leadership
    Increased visibility in scientific committees, editorial boards, or as a conference keynote speaker would establish her as a thought leader in her field.

📘 Education:

Dr. Roh’s academic journey began with a Bachelor of Science in Microbiology from the College of Natural Sciences at Chungbuk National University (2007). Motivated to delve deeper into biomedical research, she pursued her Master’s degree in Life Pharmacy (2009), followed by a Ph.D. in Pharmaceutical Function with a focus on biochemistry (2012) at the College of Pharmacy in the same university. Her graduate and doctoral training provided her with a robust understanding of molecular biology, pharmacology, and biochemical mechanisms, forming the backbone of her current work in dermatological science and cosmetic pharmacology. The interdisciplinary nature of her studies laid the groundwork for her specialization in skin biology, UV-induced skin damage, and pigmentation-related drug discovery. Her academic foundation is both broad and deep, equipping her with the necessary tools to explore innovative solutions for skin health through cosmetic science.

🧪 Experience:

Dr. Eunmiri Roh currently serves as an Assistant Professor at the Department of Cosmetic Science, Kwangju Women’s University, where she leads research on cosmetic pharmacology, focusing on skin cancer prevention and pigmentation disorders. Before joining academia, she gained valuable research experience at globally recognized institutions such as The Hormel Institute, University of Minnesota, where she was awarded for outstanding scientific contributions. She has collaborated in multidisciplinary teams working on skin photoaging, UV protection, anti-inflammatory pathways, and novel cosmetic drug formulations. Her work spans in vitro and in vivo studies, biochemical analysis, and formulation science. Dr. Roh also contributes to educational excellence, guiding undergraduate and graduate students in research methodologies and scientific writing. Her blend of practical, clinical, and research experience strengthens her impact in both the cosmetic and biomedical sectors. She is known for her rigorous scientific approach and her drive to translate laboratory findings into real-world applications.

🏅 Awards and Honors:

Dr. Roh has received numerous accolades for her pioneering research in molecular pharmacology and cosmetic science. She was honored with the Outstanding Poster Presentation Award from the Korean Society of Microbiology and Biotechnology in June 2022, recognizing her innovative insights into skin-related biochemical mechanisms. Similarly, she earned the Outstanding Poster Presentation Award from the Korean Society of Cancer Prevention in November 2021 for her work on chemopreventive agents. Earlier, in 2019, she received the Summer Research Retreat Award (2nd place) from The Hormel Institute, University of Minnesota—an acknowledgment of her collaborative contributions to cancer biology. These awards underscore her reputation for research excellence, innovation, and dedication to advancing the fields of dermatology and cosmetology. Her consistent recognition at both national and international levels reflects her commitment to impactful science and her growing influence in molecular dermatology and cosmetic formulation research.

🔬 Research Focus:

Dr. Roh’s research primarily focuses on molecular and cellular targets involved in carcinogenesis, skin aging, and pigmentation. Her studies aim to understand the biochemical pathways influenced by solar UV radiation, and their role in inducing skin cancer and photoaging. She also explores mechanisms of melanogenesis, contributing to the discovery of anti-hyperpigmentation agents. A distinctive element of her work is the translation of pharmacological findings into cosmetic applications, bridging the gap between biochemistry and skincare innovation. Her recent work includes green tea polyphenols, sesame glycoproteins, and natural bioactives for UV protection. She also investigates novel formulations for transdermal drug delivery and anti-inflammatory responses in skin cells. Her holistic approach encompasses in vitro, in vivo, and 3D skin models, emphasizing both efficacy and safety. Her contributions are instrumental in developing scientifically validated cosmetics and preventive strategies against UV-induced damage and pigment disorders.

📚 Publications Top Notes:

  1. 🧴 Evaluation and analysis of major competency achievement in beauty and cosmetics students – J Korean Soc Cosmetol (2024)

  2. 🌿 Protective Effects of Sesame Glycoproteins on UV-Induced Skin Aging – Pharmaceuticals (2024)

  3. ☀️ Orobol suppresses development of cutaneous SCC – Biochem Pharmacol (2023)

  4. 💊 Topical Rocuronium Bromide Formulation for Skin Delivery – Int J Mol Sci (2023)

  5. 🧪 Higenamine reduces fine-dust-induced MMP-1 in keratinocytes – Plants (2023)

  6. 🔥 Targeting IKKβ in acetaminophen-induced hepatotoxicity – Pharmaceutics (2023)

  7. 🌸 Lotusine inhibits UV-induced MMP-1 – Plants (2022)

  8. 🔍 Structural basis of multifunctional roles of Ints3 C-terminal domain – J Biol Chem (2021)

  9. 🧬 GSK3β and WT1 in tumor progression – Cancer Res (2021)

  10. 🌞 Effectiveness of FDA-approved sunscreens against UV damage – Cells (2020)

🔚 Conclusion:

Dr. Eunmiri Roh is a highly qualified and outstanding researcher whose scientific contributions to dermatological pharmacology, cosmetic biochemistry, and skin health are both innovative and impactful. Her robust publication record, research awards, and international collaborations indicate that she is well-positioned to receive recognition such as the Best Researcher Award. With minor enhancements in grant leadership, mentorship roles, and translational outcomes, her academic profile could rise even further.

Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Dr. Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Naoki Harada, Osaka Metropolitan University, Japan

Naoki Harada is an Associate Professor at Osaka Metropolitan University, Japan, with extensive expertise in molecular biology, biochemistry, endocrinology, and nutrition. He earned his Ph.D. in Life Sciences from Osaka Prefecture University in 2007. Over the past two decades, Harada has made significant contributions to understanding the physiological and biochemical mechanisms underpinning metabolic diseases, particularly type 2 diabetes. His research, characterized by high citation impact (H-index of 25), centers on pancreatic β-cell function and metabolic regulation. He has published 77 peer-reviewed articles and holds a patent related to therapeutic interventions. Harada has collaborated with leading scientists like Professors Hiroshi Inui and Ryoichi Yamaji, strengthening his academic footprint in both national and international circles. A member of multiple scientific societies, Harada continues to influence the field through impactful research, industry collaboration, and educational leadership.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Consistent Research Output

    • 77 peer-reviewed publications in reputable journals (SCI, Scopus).

    • Recent high-impact studies published in Journal of Biological Chemistry, Scientific Reports, and FASEB BioAdvances.

    • Active research profile with an H-index of 25 and over 1,785 citations.

  2. Innovative Scientific Contributions

    • Identified REDD2 as a novel therapeutic target for type 2 diabetes—bridging basic research with translational medicine.

    • Works across disciplines such as molecular biology, endocrinology, and nutritional biochemistry.

  3. Project Leadership & Industry Engagement

    • Led or participated in 14 major research projects.

    • 5 consultancy/industry-based projects, reflecting application-oriented research.

  4. Academic and Collaborative Network

    • Strong academic collaborations with Professors Hiroshi Inui and Ryoichi Yamaji.

    • Member of prestigious scientific societies (e.g., Japanese Biochemical Society, Japan Society of Nutrition and Food Science).

  5. Scientific Versatility

    • Contributions span fundamental mechanisms (e.g., oxidative stress, insulin signaling) to dietary interventions (e.g., mogrol, oleamide).

    • Demonstrates ability to bridge molecular insights with systemic physiological outcomes.

⚙️ Areas for Improvement:

  1. International Visibility and Engagement

    • Expanding participation in international conferences and editorial boards could elevate his global scientific standing.

    • Pursuing cross-border collaborations would further enrich the translational value of his work.

  2. Commercialization and Patent Activity

    • While one patent is noted, increased focus on intellectual property development and biomedical commercialization could further validate his applied research strength.

  3. Outreach and Communication

    • More active public science communication (e.g., webinars, policy advocacy, media coverage) would amplify the societal impact of his research.

🎓 Education:

Naoki Harada received his Ph.D. in Life Sciences from Osaka Prefecture University, Osaka, Japan, in September 2007. His doctoral studies laid the foundation for his interdisciplinary research in molecular biology, biochemistry, and endocrinology. Harada’s academic path was driven by a keen interest in the cellular and molecular mechanisms underlying metabolic regulation, particularly in relation to glucose homeostasis and pancreatic function. His education provided him with a solid grounding in experimental techniques, critical thinking, and scientific communication, which have become hallmarks of his later work. The institution, known for excellence in biosciences, enabled Harada to cultivate a strong research acumen. His academic training was complemented by exposure to applied research, linking basic science with clinical and nutritional applications—an approach that he has continued to emphasize throughout his career. His strong educational background plays a pivotal role in his current research endeavors and professional development.

💼 Experience:

Dr. Naoki Harada began his academic career in 2008 as an Assistant Professor at the Graduate School of Life and Environmental Sciences, Osaka Prefecture University. He was promoted to Lecturer in 2015, and subsequently to Associate Professor in 2019. Since 2022, he has served as Associate Professor at the Graduate School of Agriculture, Osaka Metropolitan University. Harada has consistently combined teaching with intensive research, mentoring graduate students while advancing his lab’s focus on metabolic diseases and endocrine physiology. His experience includes leading 14 research projects, consulting on 5 industry-linked nutrition initiatives, and co-authoring over 75 scientific papers. His experience reflects a blend of academic leadership, scientific innovation, and multidisciplinary collaboration. Notably, Harada’s role in identifying REDD2 as a therapeutic target exemplifies his contribution to translational science. He maintains strong academic partnerships and actively contributes to several professional societies, making him a respected figure in Japan’s scientific community.

🔬 Research Focus:

Naoki Harada’s research is at the intersection of molecular biology, endocrinology, and nutrition science, with a particular focus on pancreatic β-cell physiology and glucose metabolism. He investigates how oxidative stress, hormonal signals, and metabolic regulators influence insulin secretion and β-cell viability. One of his pivotal contributions is identifying the REDD2 gene as a negative regulator of β-cell function, offering novel therapeutic targets for type 2 diabetes mellitus. His studies also explore nutrient-sensing pathways, G-protein-coupled receptors, and hormonal modulation of energy metabolism. Harada’s recent work delves into the effects of dietary compounds like mogrol and oleamide on metabolic health, linking molecular mechanisms to real-world dietary interventions. His ability to bridge bench science with clinical and nutritional applications sets his research apart. Through collaborations with leading experts and high-impact publications, Harada continues to advance knowledge in the prevention and treatment of metabolic disorders.

📚 Publications Top Notes:

  • 🧬 REDD2 confers pancreatic β-cell dysfunction in high-fat diet-fed mice – Journal of Biological Chemistry, 2025

  • 🦷 Androgens suppress ST3GAL1/4, modulating mucin glycosylation and microbiota in mice – Bioscience, Biotechnology, and Biochemistry, 2025

  • 🍟 CRTC1 in MC4R cells regulates dietary fat intake – FASEB BioAdvances, 2024

  • 💉 Insulin reduces ER stress-induced apoptosis in INS-1 β-cells – Physiological Reports, 2024

  • 🍬 Mogrol activates GPBAR1 and insulin secretion, alleviates hyperglycemia – Scientific Reports, 2024

  • 🔥 Androgen receptor suppresses β-adrenoceptor-mediated thermogenesis – Journal of Biological Chemistry, 2022

  • 🏥 Age-dependent sex differences in NAFLD in TSOD and db/db mice – PLOS ONE, 2022

  • 🐭 Dietary oleamide attenuates obesity in caged mice – Bioscience, Biotechnology, and Biochemistry, 2022

  • 🌿 Curcumin targets GPR55 receptor – npj Science of Food, 2022

  • 💪 Oleamide rescues muscle atrophy in small-caged mice – British Journal of Nutrition, 2021

🧾 Conclusion:

Dr. Naoki Harada demonstrates a clear trajectory of research excellence, grounded in scientific rigor and driven by impactful biomedical questions. His ability to identify molecular mechanisms (e.g., REDD2’s role in β-cell dysfunction) and propose therapeutic directions sets him apart as a leading academic in metabolic disease research. His publication record, industry collaborations, and professional memberships underscore a mature and influential academic career.

Abdulatif AL-Haj | Cytoskeleton Cell Motility | Innovative Research Award

Published on by Cell Biologist

Dr. Abdulatif AL-Haj | Cytoskeleton Cell Motility | Innovative Research Award

Dr. Abdulatif AL-Haj | Ruhr Universität Bochum | Germany

Dr. Abdulatif Al Haj is a highly accomplished biochemist and molecular cardiology researcher originally from Syria, currently residing in Germany. With extensive academic and professional experience across Europe and the Middle East, Dr. Al Haj has built a multidisciplinary career in molecular biology, biotechnology, and medical education. He holds a doctorate in biology and biotechnology, with a strong focus on actin dynamics and cardiovascular disease. Fluent in Arabic, German, English, and French, he has effectively bridged scientific research with public health, education, and social integration roles. His work includes teaching, paramedic service during the pandemic, and involvement in migrant integration and healthcare initiatives. He has contributed to peer-reviewed publications and collaborated with notable researchers in Germany. Dr. Al Haj exemplifies international scientific cooperation and interdisciplinary application of biosciences for societal benefit.

publication profile:

scopus

🔍 Strengths for the Award:

  • 🔬 Cutting-Edge Research: Key discoveries in actin cytoskeleton regulation and thymosin beta4′s role in cardiac repair

  • 🌍 Global Impact: Extensive collaborations in Germany and Syria, advancing both education and research

  • 📚 Scientific Output: Author of multiple high-impact journal articles and presenter in international scientific symposia

  • 👨‍🏫 Cross-disciplinary Excellence: Combines life sciences, education, and healthcare

  • 🧪 Innovative Thinking: Integrated research on cofilin/ADF, Arp2/3 complex, and cardiomyocyte remodeling

🚧 Areas for Improvement:

  • Broader dissemination of findings through more international conferences

  • Increase involvement in grant-funded principal investigator (PI) roles

  • Enhance digital presence via scientific networking platforms (e.g., ResearchGate, ORCID)

🎓 Education :

Dr. Al Haj earned his diploma and Master’s degrees in Biotechnology and Biochemistry from the University of Damascus, Syria. He later completed a Doctorate in Biology and Biotechnology with a dissertation on the modulation of cofilin/ADF and thymosin beta4 in cell migration. His academic pursuits also include studies in Educational Planning, Natural Sciences, and Microbiology at the Technical University of Applied Sciences Berlin and Ruhr University Bochum. Additionally, he undertook postgraduate training in Education and Psychology, Business English, and quality management under TÜV-certified programs. Dr. Al Haj further enriched his academic repertoire with continuous professional development courses in process management, norm standards (ISO 9001), and nutrition. His commitment to lifelong learning reflects a passion for combining theoretical science with applied clinical and educational practices.

🧪 Experience :

Dr. Al Haj has accumulated extensive research and teaching experience across several prestigious institutions. At the Ruhr University Bochum, he worked with Prof. Hans Georg Mannherz on actin-regulating proteins, contributing to innovative cardiology research. He held posts at Catholic and Central Clinics as a scientist, served as a paramedic at Herne Vaccination Center, and worked as a social worker and integration coach. His academic duties included teaching biology, chemistry, and physics, and serving as an Arabic language teacher in Berlin. Additionally, Dr. Al Haj took on project management and quality assurance roles at LVQ Further Education gGmbH and underwent TÜV training for process management. His unique blend of clinical, educational, and social service roles highlights his commitment to interdisciplinary collaboration and societal contribution.

🔬 Research Focus :

Dr. Al Haj’s research centers on molecular and experimental cardiology, cytoskeletal proteins (cofilin/ADF), and cell migration. His doctoral and postdoctoral work explored the effects of thymosin beta4 and actin-regulating proteins on cellular motility—essential for understanding cardiac development and cancer metastasis. His published work includes significant studies on the Arp2/3 complex, actin dynamics, and the influence of sGC activators on cardiac cells from hypertensive and heart failure patients. Beyond molecular cardiology, he has explored radioimmunoassay techniques, EBV-associated gastric carcinoma, and embryological development of cardiac muscle from branchial arch progenitors. His multidisciplinary approach blends biochemistry, histology, anatomy, and clinical diagnostics, bridging basic research with therapeutic applications. His ongoing interest in student assessment and e-learning underscores a commitment to scientific education and training.

📚 Publications Top Notes :

  1. 🧬 Inhibition of Arp2/3 Complex after ADP-Ribosylation of Arp2 by Binary Clostridioides Toxins – Cells, 2022

  2. ❤️ sGC Activator Causes Beneficial Remodeling in Cardiomyocytes from Hypertensive Rats and Heart Failure Patients – Front. Physiol.

  3. 🧠 Chicken Second Branchial Arch Progenitor Cells Contribute to Heart Musculature In Vitro and In Vivo – Developmental Dynamics, 2020

  4. 🧫 Characteristics of Gastric Carcinoma Associated with Epstein Barr Virus in Algeria – Der Pharmacia Lettre, 2017

  5. 🦴 Etiology and Pathogenesis of Arthrofibrosis at the Cellular Level – Arthroscopy, 2016

  6. 🧪 HeLa Cells and the Human Colon Carcinoma BE, 3LNLN and EB3 Cell Lines – Dissertation Work

  7. 🎓 Research on Assessing Students’ Academic Performance in Bloom’s Cognitive Level

🧾 Conclusion :

Dr. Abdulatif Al Haj is a strong candidate for the Innovative Research Award, distinguished by his relentless pursuit of molecular innovation, interdisciplinary approach, and commitment to public health and education. His work on actin-binding proteins and cardiac regeneration holds promising implications for heart disease treatment and personalized medicine. His track record demonstrates scientific creativity, rigor, and societal relevance.